Impact of sex differences on patients with neuroendocrine neoplasms during hospital admission
Background: Sex disparities are known modifiers of health and disease. In neuroendocrine neoplasms (NENs), sex-based differences have been observed in the epidemiology and treatment-related side effects. Objectives: To examine sex differences in demographics, diagnoses present during hospital admiss...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-12-01
|
| Series: | Therapeutic Advances in Medical Oncology |
| Online Access: | https://doi.org/10.1177/17588359241292271 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850257275329970176 |
|---|---|
| author | Wan Ying Tan Laura D. Cramer Namrata Vijayvergia Maryam Lustberg Pamela L. Kunz |
| author_facet | Wan Ying Tan Laura D. Cramer Namrata Vijayvergia Maryam Lustberg Pamela L. Kunz |
| author_sort | Wan Ying Tan |
| collection | DOAJ |
| description | Background: Sex disparities are known modifiers of health and disease. In neuroendocrine neoplasms (NENs), sex-based differences have been observed in the epidemiology and treatment-related side effects. Objectives: To examine sex differences in demographics, diagnoses present during hospital admission, comorbidities, and outcomes of hospital course among hospitalized patients with NENs. Design: Retrospective analysis. Methods: A descriptive analysis of sex differences was performed on patients with NENs discharged from U.S. community hospitals in 2019 from the National Inpatient Sample (NIS), Healthcare Cost and Utilization Project, and Agency for Healthcare Research and Quality. Results: A total of 7334 patients with NENs were identified; 4284 patients had primary NENs, and 3050 patients had metastatic NENs. In total, 48.7% were males and 51.3% were females. Distributions of race and ethnicity, and payer types differed by sex ( p < 0.001 and p = 0.027, respectively). For race and ethnicity, there were more females in White, Black, and Native American races, and Hispanic ethnicity. For payer types, female predominance was seen with Medicare, Medicaid, private insurance, and self-pay groups. Sex differences were seen in diagnosis made during hospital stay. In all NENs, oral ( p = 0.036) and neurologic ( p < 0.001) diagnoses were more common in females; ascites ( p = 0.002), dysphagia ( p = 0.002), biliary ductal obstruction ( p = 0.014), and jaundice ( p = 0.048) were more common in males. In primary NENs, ascites ( p < 0.001) was male predominant. In metastatic NENs, dysphagia ( p = 0.003) and jaundice ( p = 0.034) were male predominant, whereas females had more headaches ( p < 0.001). Nausea and vomiting were female predominant in all NENs ( p < 0.001), primary ( p = 0.044), and metastatic ( p < 0.001) NENs. For comorbidities, arthropathies ( p < 0.001), depression ( p < 0.001), hypothyroidism ( p < 0.001), other thyroid disorders ( p < 0.001), chronic pulmonary disease ( p = 0.002), and obesity ( p < 0.001) were female predominant. Conclusion: There were sex differences in the race and ethnicity, payer types, diagnoses present during hospital admission, and comorbidities among the 2019 NIS hospital discharge sample of patients with NENs. |
| format | Article |
| id | doaj-art-98710cbfd07c41e2855622fe4246dd71 |
| institution | OA Journals |
| issn | 1758-8359 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Medical Oncology |
| spelling | doaj-art-98710cbfd07c41e2855622fe4246dd712025-08-20T01:56:28ZengSAGE PublishingTherapeutic Advances in Medical Oncology1758-83592024-12-011610.1177/17588359241292271Impact of sex differences on patients with neuroendocrine neoplasms during hospital admissionWan Ying TanLaura D. CramerNamrata VijayvergiaMaryam LustbergPamela L. KunzBackground: Sex disparities are known modifiers of health and disease. In neuroendocrine neoplasms (NENs), sex-based differences have been observed in the epidemiology and treatment-related side effects. Objectives: To examine sex differences in demographics, diagnoses present during hospital admission, comorbidities, and outcomes of hospital course among hospitalized patients with NENs. Design: Retrospective analysis. Methods: A descriptive analysis of sex differences was performed on patients with NENs discharged from U.S. community hospitals in 2019 from the National Inpatient Sample (NIS), Healthcare Cost and Utilization Project, and Agency for Healthcare Research and Quality. Results: A total of 7334 patients with NENs were identified; 4284 patients had primary NENs, and 3050 patients had metastatic NENs. In total, 48.7% were males and 51.3% were females. Distributions of race and ethnicity, and payer types differed by sex ( p < 0.001 and p = 0.027, respectively). For race and ethnicity, there were more females in White, Black, and Native American races, and Hispanic ethnicity. For payer types, female predominance was seen with Medicare, Medicaid, private insurance, and self-pay groups. Sex differences were seen in diagnosis made during hospital stay. In all NENs, oral ( p = 0.036) and neurologic ( p < 0.001) diagnoses were more common in females; ascites ( p = 0.002), dysphagia ( p = 0.002), biliary ductal obstruction ( p = 0.014), and jaundice ( p = 0.048) were more common in males. In primary NENs, ascites ( p < 0.001) was male predominant. In metastatic NENs, dysphagia ( p = 0.003) and jaundice ( p = 0.034) were male predominant, whereas females had more headaches ( p < 0.001). Nausea and vomiting were female predominant in all NENs ( p < 0.001), primary ( p = 0.044), and metastatic ( p < 0.001) NENs. For comorbidities, arthropathies ( p < 0.001), depression ( p < 0.001), hypothyroidism ( p < 0.001), other thyroid disorders ( p < 0.001), chronic pulmonary disease ( p = 0.002), and obesity ( p < 0.001) were female predominant. Conclusion: There were sex differences in the race and ethnicity, payer types, diagnoses present during hospital admission, and comorbidities among the 2019 NIS hospital discharge sample of patients with NENs.https://doi.org/10.1177/17588359241292271 |
| spellingShingle | Wan Ying Tan Laura D. Cramer Namrata Vijayvergia Maryam Lustberg Pamela L. Kunz Impact of sex differences on patients with neuroendocrine neoplasms during hospital admission Therapeutic Advances in Medical Oncology |
| title | Impact of sex differences on patients with neuroendocrine neoplasms during hospital admission |
| title_full | Impact of sex differences on patients with neuroendocrine neoplasms during hospital admission |
| title_fullStr | Impact of sex differences on patients with neuroendocrine neoplasms during hospital admission |
| title_full_unstemmed | Impact of sex differences on patients with neuroendocrine neoplasms during hospital admission |
| title_short | Impact of sex differences on patients with neuroendocrine neoplasms during hospital admission |
| title_sort | impact of sex differences on patients with neuroendocrine neoplasms during hospital admission |
| url | https://doi.org/10.1177/17588359241292271 |
| work_keys_str_mv | AT wanyingtan impactofsexdifferencesonpatientswithneuroendocrineneoplasmsduringhospitaladmission AT lauradcramer impactofsexdifferencesonpatientswithneuroendocrineneoplasmsduringhospitaladmission AT namratavijayvergia impactofsexdifferencesonpatientswithneuroendocrineneoplasmsduringhospitaladmission AT maryamlustberg impactofsexdifferencesonpatientswithneuroendocrineneoplasmsduringhospitaladmission AT pamelalkunz impactofsexdifferencesonpatientswithneuroendocrineneoplasmsduringhospitaladmission |